CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 6,170 enrolled
Drug / intervention
same type infusion of main HPA antigenprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03408158
NCT03408158N/ACompleted

Multi-center Study in the Frequency of HPA Antibodies and the Distribution of Antigen and Antibodies in Chinese Blood Disease Patients

Guangzhou First People's Hospital·interventional·Posted Jan 23, 2018·Updated Aug 12, 2021

In Brief

A clinical study evaluating same type infusion of main HPA antigen for Blood Disease and 2 related conditions. Completed, enrolled 6,170 participants across 1 site.

Detailed Summary

By detecting platelet antibodies of participants and then further to identify their genotype and analyzing laboratory examination, the investigators will obtain positive frequency of HPA antibodies, the distribution of HPA antigen and antibodies, effect of matching platelet transfusion, all of which in favor of draw a conclusion that it is very important to carry out HPA antibody detection and matching transfusion in early phase.

Study Details

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJan 23, 2018
Enrollment StartJan 1, 2017
Primary CompletionDec 31, 2020
TodayJul 2, 2026
Enrollment to primary: 4 yearsPosted 8.4 years ago

Interventions

same type infusion of main HPA antigenprocedure

Compare the differences of platelet count between participants with same type infusion of main HPA antigen and not